Biorasi is a global full-service Clinical Research Organization, widely recognized as the Leading Biosimilars CRO. Delivering Clinical Research Optimized™ for Biosimilar clinical trials proves Biorasi succeeds in some of the most complex trials in the industry. Biorasi has spent a decade successfully optimizing the development of follow-on drugs (ANDA and 505(b)(2)) and complex biologics before naturally becoming the leaders in the Biosimilars market.
The path to bringing an innovative new drug or advanced medical device to market is fraught with difficulties: study design, obtaining regulatory approval, compliance adherence, subject recruitment, data analysis, and countless more. Biorasi provides the vital services that sponsors need to successfully navigate the entire process. Through our Clinical Research Optimized™ solution, powered by our groundbreaking TALOS™ platform, we are able to identify the most optimal outcome for a specific research condition. Our experience project teams are guided by TALOS™ to successfully deliver your clinical studies. It guarantees optimal results which always meet our five key criteria – Quality, Time, Acceptance, Cost, and Service.